MITALAB BECOMES A DISTRIBUTION PARTNER OF ILLUMINA’S PRODUCTS IN VIETNAM
In March, 2024, Mitalab was officially appointed as Illumina’s distributor in Vietnam for products to accelerate genomic discoveries and fight disease.
Illumina has been a pioneer in genomics for more than two decades, and together with channel partners empowers researchers, scientists, to advance their discoveries and fight disease, while making genomics sustainable and accessible to more people.
“We are excited giant genomic solution Illumina has selected Mitalab to accelerate the adoption and broaden the reach of NGS into Vietnam,” said Ms. Van Anh Doan, Mitalab Director.
Ms. Doan Van Anh (Director of Mitalab) and Mr. Nicholas Tan (Illumina Commercial Lead South Asia)
As known, Vietnam has high rates of antimicrobial-resistant (AMR) bacterial infections in hospital patients. Besides, the Country has about 182,000 new cases of cancer each year with 122,000 people dying, which is 18 times higher than deaths from traffic accidents.
It is reported in the media that more than 12 million Vietnamese people carry the genetic variant that causes thalassemia, a recessive genetic blood disorder and currently there is no routine genetic testing for this disease.
To promptly detect and provide timely treatment regimens for patients, diagnostic technology based on genetic research data is an important indicator in the application and treatment of cancer worldwide globally, especially in the goal of shifting from a traditional one-size- fits all approach to one that is tailored for the individual.
“We believe there needs to be a far greater representation of Vietnamese genomes in datasets to help fight diseases such as Thalassemia,” said Nicholas Tan, Illumina Commercial Lead South Asia.
Mr. Nicholas expressed his confidence that this cooperation with Mitalab will contribute to raising the level of researchers and supporting the Vietnamese health industry ecosystem to transform from traditional methods to integrating systematic research tools genes, improving diagnosis and treatment more effectively and accurately.
With the mission of accompanying the development of healthcare, Mitalab will coordinate closely with Illumina to provide effective and comprehensive laboratory solutions for customers, focusing on the genetic segment to implement the overall solution strategy, contributing value to the community, contributing to “Elevating the quality of testing in Vietnam”.